
Stonegate Updates Coverage on Burcon Nutrascience: Commercial Momentum Builds, but 2H Ramp Remains Key
Burcon Nutrascience's 1Q27 results show accelerating commercialization with revenue up 273% year-over-year, but the company faces a substantial second-half ramp to meet its CY26 sales target.
Read full story


























